CD274 and neoplasm: Collectively, our findings suggest that DTP-PDT-induced tumor-specific immune responses may be effective in sensitizing tumors towards PD-L1 blockade, and combining DTP-PDT with PD-L1 blockade could be a promising approach in treating metastatic TNBC.